United States · FDA National Drug Code directory
Daptomycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-179_bbf5eb07-b225-4bb4-a3d8-fad8ef6282c6
- Product NDC
- 25021-179
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Daptomycin
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180115
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPTOMYCIN — 350 mg/7mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (25021-179-15) / 7 mL in 1 VIAL · 25021-179-15
- 10 VIAL in 1 CARTON (25021-179-16) / 7 mL in 1 VIAL · 25021-179-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →